Titre : Inositol phosphates

Inositol phosphates : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prostatic Neoplasms
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Inositol phosphates : Questions médicales les plus fréquentes", "headline": "Inositol phosphates : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Inositol phosphates : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-23", "dateModified": "2025-04-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Inositol phosphates" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Oses phosphates", "url": "https://questionsmedicales.fr/mesh/D013403", "about": { "@type": "MedicalCondition", "name": "Oses phosphates", "code": { "@type": "MedicalCode", "code": "D013403", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D09.894" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inositol 1,4,5-trisphosphate", "alternateName": "Inositol 1,4,5-Trisphosphate", "url": "https://questionsmedicales.fr/mesh/D015544", "about": { "@type": "MedicalCondition", "name": "Inositol 1,4,5-trisphosphate", "code": { "@type": "MedicalCode", "code": "D015544", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D09.894.480.350" } } }, { "@type": "MedicalWebPage", "name": "Acide phytique", "alternateName": "Phytic Acid", "url": "https://questionsmedicales.fr/mesh/D010833", "about": { "@type": "MedicalCondition", "name": "Acide phytique", "code": { "@type": "MedicalCode", "code": "D010833", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D09.894.480.700" } } } ], "about": { "@type": "MedicalCondition", "name": "Inositol phosphates", "alternateName": "Inositol Phosphates", "code": { "@type": "MedicalCode", "code": "D007295", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Adolfo Saiardi", "url": "https://questionsmedicales.fr/author/Adolfo%20Saiardi", "affiliation": { "@type": "Organization", "name": "Medical Research Council Laboratory for Molecular Cell Biology, University College London, WC1E6BT, London, UK. Electronic address: a.saiardi@ucl.ac.uk." } }, { "@type": "Person", "name": "Henning J Jessen", "url": "https://questionsmedicales.fr/author/Henning%20J%20Jessen", "affiliation": { "@type": "Organization", "name": "Institute of Organic Chemistry & CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany." } }, { "@type": "Person", "name": "Gabriel Schaaf", "url": "https://questionsmedicales.fr/author/Gabriel%20Schaaf", "affiliation": { "@type": "Organization", "name": "Department of Plant Nutrition, Institute of Crop Science and Resource Conservation, Rheinische Friedrich-Wilhelms-University Bonn, Bonn, Germany. gabriel.schaaf@uni-bonn.de." } }, { "@type": "Person", "name": "Debabrata Laha", "url": "https://questionsmedicales.fr/author/Debabrata%20Laha", "affiliation": { "@type": "Organization", "name": "Medical Research Council Laboratory for Molecular Cell Biology, University College London, WC1E6BT, London, UK." } }, { "@type": "Person", "name": "Stephen B Shears", "url": "https://questionsmedicales.fr/author/Stephen%20B%20Shears", "affiliation": { "@type": "Organization", "name": "Inositol Signaling Section, NIEHS, 111, Alexander Drive, Research Triangle Park, Durham, NC 27709, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Presence of HPV in prostate tissue from patients submitted to prostate biopsy.", "datePublished": "2023-01-13", "url": "https://questionsmedicales.fr/article/36651430", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/acb371205" } }, { "@type": "ScholarlyArticle", "name": "Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.", "datePublished": "2022-09-24", "url": "https://questionsmedicales.fr/article/36253300", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clgc.2022.09.007" } }, { "@type": "ScholarlyArticle", "name": "The mendelian randomized study revealed the association of prostatitis with prostate cancer risk.", "datePublished": "2024-10-20", "url": "https://questionsmedicales.fr/article/39428439", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-76355-4" } }, { "@type": "ScholarlyArticle", "name": "Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.", "datePublished": "2023-05-26", "url": "https://questionsmedicales.fr/article/37271051", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cmpb.2023.107624" } }, { "@type": "ScholarlyArticle", "name": "Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.", "datePublished": "2023-03-14", "url": "https://questionsmedicales.fr/article/36917412", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11255-023-03531-2" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Glucides", "item": "https://questionsmedicales.fr/mesh/D002241" }, { "@type": "ListItem", "position": 3, "name": "Oses phosphates", "item": "https://questionsmedicales.fr/mesh/D013403" }, { "@type": "ListItem", "position": 4, "name": "Inositol phosphates", "item": "https://questionsmedicales.fr/mesh/D007295" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Inositol phosphates - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Inositol phosphates", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Inositol phosphates", "description": "Comment diagnostiquer un déséquilibre en inositol phosphates ?\nQuels tests sont utilisés pour évaluer les inositol phosphates ?\nLes inositol phosphates sont-ils mesurables dans les tissus ?\nY a-t-il des marqueurs spécifiques pour les inositol phosphates ?\nLes tests génétiques sont-ils utiles pour les inositol phosphates ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Prostatic+Neoplasms&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Inositol phosphates", "description": "Quels symptômes sont associés à un déséquilibre en inositol phosphates ?\nLes inositol phosphates affectent-ils la santé mentale ?\nY a-t-il des signes physiques d'un déséquilibre ?\nLes inositol phosphates influencent-ils le métabolisme ?\nPeut-on observer des symptômes neurologiques ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Prostatic+Neoplasms&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Inositol phosphates", "description": "Comment prévenir les déséquilibres en inositol phosphates ?\nLes suppléments sont-ils nécessaires pour la prévention ?\nY a-t-il des habitudes de vie à adopter ?\nLes consultations médicales sont-elles importantes ?\nLes facteurs environnementaux influencent-ils les niveaux ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Prostatic+Neoplasms&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Inositol phosphates", "description": "Quels traitements existent pour les déséquilibres en inositol phosphates ?\nLes médicaments peuvent-ils aider avec les inositol phosphates ?\nY a-t-il des thérapies alternatives pour les inositol phosphates ?\nComment les changements alimentaires aident-ils ?\nLes traitements sont-ils personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Prostatic+Neoplasms&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Inositol phosphates", "description": "Quelles complications peuvent survenir avec des déséquilibres ?\nLes inositol phosphates sont-ils liés à des maladies chroniques ?\nY a-t-il des risques pour la santé reproductive ?\nLes complications neurologiques sont-elles fréquentes ?\nLes complications psychologiques sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Prostatic+Neoplasms&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Inositol phosphates", "description": "Quels sont les facteurs de risque pour les déséquilibres ?\nL'âge influence-t-il les niveaux d'inositol phosphates ?\nLes maladies métaboliques sont-elles un facteur de risque ?\nLe mode de vie sédentaire est-il un risque ?\nLes facteurs environnementaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Prostatic+Neoplasms&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un déséquilibre en inositol phosphates ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins peuvent mesurer les niveaux d'inositol phosphates dans le corps." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les inositol phosphates ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests biochimiques et les analyses de métabolites urinaires sont courants." } }, { "@type": "Question", "name": "Les inositol phosphates sont-ils mesurables dans les tissus ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des biopsies peuvent être effectuées pour évaluer les niveaux dans les tissus." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs spécifiques pour les inositol phosphates ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme l'IP3 peuvent indiquer des déséquilibres dans la signalisation cellulaire." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour les inositol phosphates ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent aider à identifier des troubles métaboliques liés aux inositol phosphates." } }, { "@type": "Question", "name": "Quels symptômes sont associés à un déséquilibre en inositol phosphates ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, troubles de l'humeur et problèmes métaboliques peuvent survenir." } }, { "@type": "Question", "name": "Les inositol phosphates affectent-ils la santé mentale ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres peuvent être liés à des troubles de l'humeur comme la dépression." } }, { "@type": "Question", "name": "Y a-t-il des signes physiques d'un déséquilibre ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des troubles de la peau ou des problèmes digestifs peuvent apparaître." } }, { "@type": "Question", "name": "Les inositol phosphates influencent-ils le métabolisme ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils jouent un rôle dans la régulation du métabolisme lipidique et glucidique." } }, { "@type": "Question", "name": "Peut-on observer des symptômes neurologiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles cognitifs et de la mémoire peuvent être liés à des déséquilibres." } }, { "@type": "Question", "name": "Comment prévenir les déséquilibres en inositol phosphates ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain sont essentiels pour la prévention." } }, { "@type": "Question", "name": "Les suppléments sont-ils nécessaires pour la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments peuvent être bénéfiques, surtout en cas de carence alimentaire." } }, { "@type": "Question", "name": "Y a-t-il des habitudes de vie à adopter ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régulier et la gestion du stress peuvent aider à maintenir l'équilibre." } }, { "@type": "Question", "name": "Les consultations médicales sont-elles importantes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des bilans réguliers peuvent aider à détecter des déséquilibres précocement." } }, { "@type": "Question", "name": "Les facteurs environnementaux influencent-ils les niveaux ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines peut affecter le métabolisme des inositol phosphates." } }, { "@type": "Question", "name": "Quels traitements existent pour les déséquilibres en inositol phosphates ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments d'inositol et des modifications alimentaires peuvent être recommandés." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider avec les inositol phosphates ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments psychotropes peuvent influencer les niveaux d'inositol phosphates." } }, { "@type": "Question", "name": "Y a-t-il des thérapies alternatives pour les inositol phosphates ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des approches comme la phytothérapie peuvent être explorées, mais nécessitent des études." } }, { "@type": "Question", "name": "Comment les changements alimentaires aident-ils ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en fruits et légumes peut améliorer les niveaux d'inositol." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés selon les besoins individuels et les symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des déséquilibres ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles métaboliques, neurologiques et psychologiques peuvent se développer." } }, { "@type": "Question", "name": "Les inositol phosphates sont-ils liés à des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres peuvent être associés à des maladies comme le diabète." } }, { "@type": "Question", "name": "Y a-t-il des risques pour la santé reproductive ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des déséquilibres peuvent affecter la fertilité et la santé reproductive." } }, { "@type": "Question", "name": "Les complications neurologiques sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cognitifs peuvent survenir en cas de déséquilibre prolongé." } }, { "@type": "Question", "name": "Les complications psychologiques sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines peuvent être réversibles avec un traitement approprié et un suivi." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les déséquilibres ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation pauvre, le stress et des antécédents familiaux peuvent augmenter le risque." } }, { "@type": "Question", "name": "L'âge influence-t-il les niveaux d'inositol phosphates ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les niveaux peuvent diminuer avec l'âge, augmentant le risque de déséquilibre." } }, { "@type": "Question", "name": "Les maladies métaboliques sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions comme le diabète peuvent affecter le métabolisme des inositol phosphates." } }, { "@type": "Question", "name": "Le mode de vie sédentaire est-il un risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie inactif peut contribuer à des déséquilibres en inositol phosphates." } }, { "@type": "Question", "name": "Les facteurs environnementaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines peut perturber le métabolisme des inositol phosphates." } } ] } ] }

Sources (10000 au total)

Presence of HPV in prostate tissue from patients submitted to prostate biopsy.

Prostate cancer (PCa) is the second most frequent cancer among men in the Western population. Infections, such as the one caused by the human papillomavirus (HPV), have been shown to promote inflammat... Prostate tissue fragments were collected by prostate biopsy and subjected to polymerase chain reaction with primers for the HPV L1 gene to identify the presence of the virus.... Among 162 patients, 10 (6.2%) had HPV and in 152 (93.8%) HPV was not identified in prostate biopsies. HPV was detected in 7/95 (7.4%) of patients with PCa, in 2/55 (3.6%) of patients without PCa, and ... There were no significant levels of HPV L1 protein in prostate tissue. The findings suggest the absence of HPV oncogenic activity in the prostate tissue of patients with PCa....

Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.

In this study, it was aimed to investigate the reliability of total prostate-specific antigen (t-PSA) in prostate cancer screening in hyperglycemic (≥126 mg/dL) individuals.... This research was planned as a cross-sectional retrospective study. Three hundred eleven cases which underwent biopsy with the suspicion of prostate cancer in the hospital were included in the study. ... It was determined that the t-PSA measurement was higher in the patient group with cancer (P < .001). It was determined that the median t-PSA levels of the intermediate and high cancer groups were high... As a contribution to literature, we found that the t-PSA test lost its sensitivity in cases with plasma glucose levels above normal. Loss of sensitivity may result in underdiagnosis in prostate cancer...

Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.

With emerging evidence to improve prostate cancer (PCa) screening, multiparametric magnetic prostate imaging is becoming an essential noninvasive component of the diagnostic routine. Computer-aided di... We collected 1647 fine-grained biopsy-confirmed findings, including Gleason scores and prostatitis, to form a training dataset. In our experimental framework for lesion detection, all models utilized ... An optimal model configuration with fine class granularity (prostatitis included) and OHE has scored the lesion-wise partial Free-Response Receiver Operating Characteristic (FROC) area under the curve... This paper examines several configurations for model training in the biparametric MRI setup and proposes optimal value ranges. It also shows that the fine-grained class configuration, including prosta...

Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.

To assess the efficacy of 2-core prostate biopsy in advanced prostate cancer patients. This included a retrospective analysis of 12-core prostate biopsies and a prospective validation that a reduced n... The first phase analyzed retrospective data from 12-core prostate biopsies between January 2013 and 2018. In the second phase, from January 2018 to January 2022, in a prospective setting, patients wit... In the retrospective analysis, the number of positive cores in metastatic disease was 12 in 93 (73.8%), 11 in 14 (11.1%), and 10 in 7 (5.6%) patients. Using probability analysis, 94% of patients with ... A 2-core biopsy is adequate in almost all patients with metastatic prostate cancer with PSA > 75, and this avoids excess complications and morbidity associated with a systematic 12-core prostate biops...

Prostate cancer aggressiveness and financial toxicity among prostate cancer patients.

Financial toxicity (FT) is a growing concern among cancer survivors that adversely affects the quality of life and survival. Individuals diagnosed with aggressive cancers are often at a greater risk o... PCa patients enrolled in the North Carolina-Louisiana Prostate Cancer Project (PCaP) were recontacted for long-term follow-up. The prevalence of FT in the PCaP cohort was estimated. FT was estimated u... More than one-third of PCa patients reported experiencing FT. PCa aggressiveness was significantly independently associated with high FT; high aggressive PCa at diagnosis had more than twice the risk ... Aggressive PCa was associated with high FT. Future studies should collect more information about the characteristics of men with high FT and identify additional risk factors of FT....

Is prostatic adenocarcinoma with cribriform architecture more difficult to detect on prostate MRI?

Cribriform (CBFM) pattern on prostate biopsy has been implicated as a predictor for high-risk features, potentially leading to adverse outcomes after definitive treatment. This study aims to investiga... Patients who underwent multiparametric magnetic resonance imaging (mpMRI), combined 12-core transrectal ultrasound (TRUS) guided systematic (SB) and MRI/US fusion-guided biopsy were retrospectively qu... Between 2015 and 2022, a total of 131 consecutive patients with CBFM pattern on prostate biopsy and pre-biopsy mpMRI were included. Clinical feature analysis included 1572 systematic biopsy cores (114... The extent of disease for CBFM-containing tumors is difficult to capture on mpMRI. When comparing MRI lesions of similar dimensions and PIRADS scores, CBFM-containing tumors appear to have larger canc...